Press "Enter" to skip to content

Posts published in “Day: February 11, 2021

Is Lee Bollinger an Affirmative Action and Freedom Speech Fighter?

Columbia University President Accused of Covering Up Decades of Racial Intimidation and Fraud Criminal complaints filed against Columbia President Lee C. Bollinger allege that he masterminded a $650,000 bribery, arbitration fraud, $5,000/day extortion, and judicial corruption scheme to avoid a $200 million dollar class action lawsuit, already scheduled jury trial,…

United Nations Secretary-General Appoints Michael R. Bloomberg as Special Envoy for Climate Ambition and Solutions

NEW YORK, NY – Today, United Nations Secretary-General António Guterres announced the appointment of Michael R. Bloomberg as his Special Envoy for Climate Ambition and Solutions. The COP26 High Level Climate Action Champions, Gonzalo Muñoz and Nigel Topping, also named Mr. Bloomberg the first Global Ambassador for the Race to…

No Time to waste, The Prize to repair the planet

Our Global Alliance is a network of global organisations committed to environmental action who share the ambition of The Prize to repair the planet, as well as academic and non-profit institutions and private sector alliances from around the world. Our Global Alliance and nominators are a key part of Earthshot,…

Roughly 40% of the USA’s coronavirus deaths could have been prevented, new study says

About 40% of the nation’s coronavirus deaths could have been prevented if the United States’ average death rate matched other industrialized nations, a new Lancet Commission report has found.While the Lancet Commission on Public Policy and Health in the Trump Era faulted former President Donald Trump’s “inept and insufficient” response…

Cuba produces first batch of 150,000 vial bottles of Covid-19 vaccine

Cuba produces first batch of 150,000 vial bottles of Covid-19 vaccineHavana, Feb 10 (Prensa Latina) The Cuban biopharmaceutical industry produced the first batch of 150,000 vial bottles of Soberana 02, the most advanced Covid-19 vaccine candidate, which will start phase III of clinical trials in March, the developers highlighted. The…